A series of N-(2-amino-5-substituted phenyl)benzamides (3-21) were designed, synthesized and evaluated for their inhibition of HDAC2 and their cytotoxicity in HCT116 cancer cells. Multiple compounds from this series demonstrated time-dependent binding kinetics that is rationalized using a co-complex crystal structure of HDAC2 and N-(4-aminobiphenyl-3-yl) benzamide (6). (C) 2010 Elsevier Ltd. All rights reserved.
设计、合成了一系列N -(2 - 氨基 - 5 - 取代苯基)苯甲酰胺(3 - 21),并对其抑制HDAC2的活性以及在HCT116癌细胞中的细胞毒性进行了评估。该系列中的多种化合物表现出时间依赖性结合动力学,这通过HDAC2和N -(4 - 氨基联苯 - 3 - 基)苯甲酰胺(6)的共复合物晶体结构得以合理说明。(C)2010爱思唯尔有限公司。保留所有权利。